NEW YORK (GenomeWeb News) – Knome today announced the start of its early access program for knomeClinic, a software suite for the interpretation of human genomes for biological relevance.

The software is designed to help medical researchers and clinicians interpret the human genome, and those accepted into the early access program will receive installation priority, access to pilot programs, and pre-release prototypes, Knome said. They also will have the "ability to influence knomeClinic's feature set upon general release," the Cambridge, Mass.-based firm added.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease. 

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.